Mitsu Chem Plast Limited has achieved a significant milestone by securing a Global Supplier Agreement with Arjohuntleigh Polska Sp. z o.o., marking its entry into the global healthcare supply chain. The agreement, announced on February 05, 2026, follows a comprehensive year-long validation process and approvals, positioning the company as a trusted supplier to one of the world's leading medical equipment manufacturers.

Strategic Partnership with Global Healthcare Leader

The agreement establishes Mitsu Chem Plast Limited as a global supplier to the Arjo Group, recognized as one of the world's Top 5 leading medical equipment companies. This partnership reflects the company's strong manufacturing capabilities, professional approach, consistent quality standards, and compliance with international requirements.

Product Portfolio and Healthcare Applications

Under the new agreement, Mitsu Chem Plast will supply hospital furniture parts and other related plastic accessories. These specialized products are designed to support critical healthcare functions including patient safety, caregiver ergonomics, and efficient risk management in the healthcare industry. The partnership leverages Mitsu's expertise in polymer-based molded products and technical manufacturing capabilities.

Business Impact and Growth Opportunities

The partnership creates multiple strategic advantages for Mitsu Chem Plast Limited. It strengthens the company's presence in the global furniture parts supply chain while enhancing brand visibility across international markets. The agreement also generates long-term growth opportunities by expanding the company's hospital furniture parts portfolio and supporting export-led business growth initiatives.

Market Context and Trade Relations

The engagement coincides with strengthening India-European Union trade relations, supported by the recently concluded India-EU trade agreement. This development is expected to improve export competitiveness and ease market access for specialized polymer and healthcare component manufacturers, thereby supporting Mitsu Chem Plast's long-term international business expansion strategy.

Management Commentary

Mr. Sanjay Dedhia, Managing Director of Mitsu Chem Plast Limited, expressed satisfaction with the development, stating that successfully completing the year-long validation process reflects the strength of the company's product quality, manufacturing discipline, and ability to meet stringent global standards. He emphasized that this partnership positions Mitsu as a trusted supplier in the global healthcare ecosystem and supports the company's strategy of expanding exports, diversifying the customer base, and building sustainable relationships with global leaders.

Company Performance Overview

Mitsu Chem Plast Limited operates as a certified manufacturer of polymer-based molded products, serving diverse industries including Industrial Packaging Solutions, Healthcare Products, Infrastructure Products, and Emergency Handling Solutions. The company operates four manufacturing facilities in Maharashtra, with three plants in Boisar, Tarapur, and one in Khalapur, supported by robust in-house testing and quality control systems.

Mitsu Chem Plast Limited announced strong Q3 FY26 financial results, demonstrating significant improvement in profitability metrics. The polymer-based molded products manufacturer reported robust growth across key financial parameters, with EBITDA rising 73.35% and net profit surging 217.03% compared to the same quarter last year.

Financial Performance Highlights

The company's Q3 FY26 performance showed substantial improvement in both revenue and profitability metrics. Total income grew 6.92% to ₹8,608.85 lakhs from ₹8,051.78 lakhs in Q3 FY25, while EBITDA expanded dramatically to ₹954.45 lakhs from ₹550.67 lakhs, representing a 73.35% year-on-year increase.

Nine-Month Performance

For the nine-month period ending December 31, 2025, Mitsu Chem Plast Limited maintained strong momentum with total income reaching ₹26,405.09 lakhs, up 8.94% from ₹24,237.28 lakhs in 9M FY25. EBITDA for the period grew 35.71% to ₹2,043.58 lakhs, while net profit more than doubled to ₹790.13 lakhs from ₹370.91 lakhs.

Management Insights and Growth Strategy

During the earnings conference call held on February 02, 2026, Managing Director Manish Dedhia outlined the company's strategic focus on profitable growth through operational excellence and diversification. The management emphasized their target of achieving ₹1,000 crores in annual revenue by FY 2028, supported by capacity expansion and enhanced product mix.

The company's niche products, including healthcare furniture components under the Furnastra brand, command 5-7% higher margins compared to commodity products. Management expects to maintain the niche product contribution at 15-20% while scaling overall operations.

Capacity Expansion Initiative

The company completed a significant capacity expansion during the quarter, adding approximately 655 MT per annum to take total manufacturing capacity to over 29,000 MT per annum. This expansion was commissioned by November 2025 and was funded entirely through internal accruals. Additionally, the company announced Unit 4 expansion in January 2026, adding another 900 metric tons of capacity.

Export Growth and Market Expansion

The company's export business showed steady progress, currently contributing 2.5% of total revenue across 17 countries, primarily in Europe, Canada, and Gulf regions. The export focus remains on niche healthcare furniture components, which offer better margins than domestic sales. Management expressed confidence in significant export growth following successful product approvals in international markets.

Company Overview

Mitsu Chem Plast Limited operates as a certified manufacturer of polymer-based molded products, serving diverse industries including Industrial Packaging Solutions, Healthcare Products, Infrastructure Products, and Emergency Handling Solutions. The company operates three manufacturing facilities in Maharashtra with over 51 blow molding and 20 injection molding machines, primarily catering to Original Equipment Manufacturers across chemical, pharmaceutical, dyes, agrochemical, disinfectants, diagnostic, hospital, and infrastructure furniture sectors.